The purpose of this study is to assess the efficacy of rituximab compared with placebo for the treatment of patients with active systemic lupus erythematosus (SLE). This is a multi-center trial in which patients will be followed for 18 months.
Patient must have active SLE despite treatment at the time of enrollment.
JoAnn Vega
212.774.2795
vegaj@hss.edu